The global road haulage market size is expected to reach USD 4,071.7 billion by 2025, registering a CAGR of 5.5% from 2019 to 2025 according to a study conducted by Grand View Research, Inc. The increasing demand for preserved commodities, fresh food, and perishable goods, coupled with the flourishing e-commerce industry, has triggered the demand for road haulage services. These factors are anticipated to drive the market in the coming years.
The steady expansion of the automotive and transportation industries over the years has also spurred the demand for road haulage services in recent years. Rising population and shift in residential preferences are also key factors that are expected to fuel market growth. Numerous technological advancements such as vehicle-to-vehicle communication, integrated supply chain, remote diagnostics, and autonomous driving are optimizing road transportation and increasing cargo throughput.
Additionally, the availability of several online support services such as GPS tracking and google maps are expected to augment the adoption of road haulage services. The rising demand for food commodities, local deliveries, agricultural goods, and wholesale product deliveries are anticipated to provide significant growth opportunities for the players present in the market.
Request a Free Sample Copy of Road Haulage Market Report @ https://www.radiantinsights.com/research/road-haulage-market/request-sample
Professional road haulage services are cost-efficient, easy to track, involve low idle period, offer doorstep deliveries and highly safe cargoes, and are capable of using different routes. Such benefits are encouraging the adoption of these services in manufacturing, petroleum, and infrastructure arenas. Furthermore, steadily expanding global and cross-border trade are spurring market growth. Reduction in vehicle and fuel taxes in certain countries are further boosting the adoption of road transportation.
The market is highly fragmented and characterized by high competition with the presence of established local and regional players. Companies are focusing on offering the most cost-effective, flexible, and efficient services to customers. Companies are also focusing on partnerships and mergers, with medium-sized operators to strengthen their market presence. Key players operating in the market are focusing on enhancing their global logistics networks. Numerous companies are undergoing mergers and acquisitions with third-party logistics services to provide more value-added services to customers. For instance, in May 2018, Alibaba group invested USD 1.38 billion in ZTO express to strengthen its transportation and logistics network and ensure quick parcel deliveries in China.
However, the escalation of fuel prices and fuel levies in certain economies are hindering the market growth. Moreover, a massive shortage of Heavy Goods Vehicle (HGV) drivers is reducing productivity and causing delays in the transportation of goods. These factors are further expected to challenge the growth prospects of the market.
Download Full Research Report on “Road Haulage Market” @ https://www.radiantinsights.com/research/road-haulage-market
Further key findings from the study suggest:
• In terms of the vehicle type, the light commercial vehicles segment is expected to grow prominently by 2025, registering a CAGR of more than 6% from 2019 to 2025. The significant increase in the adoption of light goods vehicle (LGVs) corresponds to the growing e-commerce industry, which requires quick deliveries of retail goods
• The domestic road haulage segment is expected to grow at a CAGR exceeding 5% from 2019 to 2025. This prominent growth is due to the increased deliveries of food commodities and other retail goods
• The food & beverage application segment is expected to register a promising CAGR owing to the rising transport of agricultural products such as bulk food commodities and field produce
• The Asia Pacific regional market is expected to witness substantial growth prospects and a CAGR exceeding 6% during the forecast period. This can be attributed to the robust roadways infrastructure and connectivity in the region
• Countries such as China and India witness high volumes of export and import of goods, which requires quick and cost-efficient freight transportation. In addition, legislative initiatives for road transport and flexible international transport policies in the Asia Pacific region are further contributing to market growth
• Key players operating in the market include CONCOR, Kindersley Transport Ltd., Gosselin Group, Monarch Transport, AM Cargo, Manitoulin Group of Companies, SLH Transport Inc., Woodside Logistics Group, and UK Haulier.
To read more reports of this category, Visit our blog: https://ictmarketporters.tumblr.com
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Beulah Transport is a family-run business, located in Enfield, Middlesex.
With over 15 years of experience in the industry.
We have built up a reliable and respected business and thrive to deliver a first-class service for all our clients.
Our wealth of experience means we can move almost anything around the UK and Europe.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
